Patents by Inventor Pamela Layton

Pamela Layton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170157291
    Abstract: Provided are transplants and methods for augmenting formation and restoration of organ and tissue, for example, bone formation, by administering autologous or allogeneic human embryonic-like adult stem cells (ELA cells). Also provided is a method for augmenting formation of tissues and organs by administering a transplant having ELA stem cells or combination of ELA stem cells.
    Type: Application
    Filed: July 7, 2016
    Publication date: June 8, 2017
    Applicants: THE BRIGHAM AND WOMEN'S HOSPITAL, INC., PARCELL LABORATORIES LLC
    Inventors: Keith D. Crawford, Pamela Layton, John M. Garvey
  • Publication number: 20150258145
    Abstract: Provided are transplants and methods for augmenting formation and restoration of organ and tissue, for example, bone formation, by administering autologous or allogeneic human embryonic-like adult stem cells (ELA cells). Also provided is a method for augmenting formation of tissues and organs by administering a transplant having ELA stem cells or combination of ELA stem cells.
    Type: Application
    Filed: December 17, 2014
    Publication date: September 17, 2015
    Inventors: Keith D. Crawford, Pamela Layton, John M. Garvey
  • Publication number: 20150010501
    Abstract: The present invention provides compositions, methods and devices for treatment of degenerative disc disease or the repair of a disc in need of repair. The composition or the formulation includes freshly isolated or culture expanded ELA cells, which can be cyropreserved. The composition or a formulation also includes in various embodiments an ELA cell population that has been differentiated into cell types having at least one characteristic of human intervertebral disc cells, such as fibroblast cells, chondrocyte cells or notochordal cells. The composition or the formulation includes in certain embodiments either a population of ELA cells provided in conjunction with one or more biocompatible molecules, therapeutic agents, or agents that induce ELA stem cell differentiation. The ELA cells are obtained from fluid or tissue from live or cadaveric (cadaverous) donors.
    Type: Application
    Filed: September 26, 2014
    Publication date: January 8, 2015
    Inventors: Keith D. Crawford, Pamela Layton, John Garvey, Jeffrey A. Gadboys
  • Publication number: 20120230966
    Abstract: Provided are transplants and methods for augmenting formation and restoration of organ and tissue, for example, bone formation, by administering autologous or allogeneic human embryonic-like adult stem cells (ELA cells). Also provided is a method for augmenting formation of tissues and organs by administering a transplant having ELA stem cells or combination of ELA stem cells.
    Type: Application
    Filed: September 24, 2010
    Publication date: September 13, 2012
    Applicants: PARCELL LABORATORIES LLC, THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Keith D. Crawford, Pamela Layton, John M. Garvey